WEIGHT LOSS & PEPTIDES
Elamipretide (SS-31)
What it is used for
FDA-approved under accelerated approval to improve muscle strength in patients with Barth syndrome who meet the label criteria. This is a condition-specific medicine, not an approved general wellness or weight-loss treatment.
COA- Form
- Subcutaneous injection
- Product status
- FDA-approved product and dosage form reference
- Availability
- Subject to clinical and pharmacy review
- Patient pricing
- $104.50 per unit
